Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Plos Neglected Tropical Diseases|December 15, 2010
Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesienseLorna M MacLean, Martin Odiit, John E Chisi, et al.Plos One|April 18, 2024
Validation of Trypanosoma cruzi inactivation techniques for laboratory useLorna M MacLean, Mark Ariyanayagam, Lalitha Sastry, et al.Plos Neglected Tropical Diseases|July 13, 2018
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discoveryLorna M MacLean, John Thomas, Michael D Lewis, et al.Cellular Microbiology|January 20, 2012
Trafficking and release of Leishmania metacyclic HASPB on macrophage invasionLorna M Maclean, Peter J O'Toole, Meg Stark, et al.Plos Neglected Tropical Diseases|October 8, 2010
Leishmania-specific surface antigens show sub-genus sequence variation and immune recognitionDaniel P Depledge, Lorna M MacLean, Michael R Hodgkinson, et al.Plos One|February 25, 2012
The orthologue of Sjögren's syndrome nuclear autoantigen 1 (SSNA1) in Trypanosoma brucei is an immunogenic self-assembling moleculeHelen P Price, Michael R Hodgkinson, Rachel S Curwen, et al.The Journal of Biological Chemistry|December 5, 2024
Pharmacological and structural understanding of the Trypanosoma cruzi proteasome provides key insights for developing site-specific inhibitorsThomas C Eadsforth, Leah S Torrie, Paul Rowland, et al.Nature|July 27, 2018
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasisSusan Wyllie, Michael Thomas, Stephen Patterson, et al.Pageof 1